CSX vs EDIT · P/E 19, rev $14.09B vs rev $32.3M
CSX Corporation (CSX) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
CSX Corporation (CSX) is a railroads company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported CSX revenue for 2025-12-31 was $14.09B. Net income was $2.89B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. CSX currently screens at market cap $61.18B and trailing P/E 19.4.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
CSX currently screens at market cap $61.18B and trailing P/E 19.4. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the CSX and EDIT stock pages for the full models.
Not investment advice.